35
Dr.Satheesh THANGARAJ, Ph.D bioMérieux Singapore Pte Ltd Antibiotic stewardship, the way forward… !!!

Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Dr.Satheesh THANGARAJ, Ph.D bioMérieux Singapore Pte Ltd

Antibiotic stewardship,

the way forward… !!!

Page 2: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM
Page 3: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Waiting Room Poster

Page 4: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Occurrence of Resistance

Evolution through natural selection can occur remarkably quickly when selection pressures are

very strong and reproductive rates are very fast

• Genes acquired by transfer of a small DNA molecule (a plasmid or transposon) from one organism to another

• Unstable in the absence of the antibiotic • Horizontal transmission • Vertical transmission (to daughter cells)

Spontaneous Mutations Gene Acquisition

Page 5: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Mechanisms of Resistance Gene Transfer

Page 6: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

A.E. Chatworthy et al. (2007) Nature Chem. Biol.

History of Antimicrobials

Bacteria can quickly become

less susceptible (or resistant) to

any drug

Page 7: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Resistant Bugs are Spreading Rapidly

Source: Centers for Disease Control and Protection (CDC)

Page 8: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

The Antibiotic Pipeline is Drying Up Antibacterial Agents Approved 1983-2007

Source: B. Spellberg et al., Clin. Infect. Dis. 38: 1279-86

(2004) (modified).

R.P. Wenzel, N. Engl. J. Med. 351: 523-526 (2004).

5,000 - 5,000,000

compounds

500

250

5

1 or 2

new drugs (may or may not be profitable)

isolation &

screening

further

screening

preclinical

studies

clinical

trials

12 – 15 years

$802 M – 1.7 B

Sources: C. O’Driscoll, Horizon Symposia 2004: Charting Chemical Space.

J. Gilbert et al. IN VIVO: The Business & Medicine Report, 21: 73-82 (2003).

J.A. DiMasi et al. J. Health Econ. 835, 1-35 (2003).

Page 9: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Use our resources wisely

9

Page 10: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Use of antibiotics

10

Source: Pew Charitable trust. Article by Tom Philpott

Page 11: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Antimicrobial stewardship

Page 12: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Use of antibiotics

12 Cosby JL et al., The lancet infectious diseases, 2007

Page 13: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Antimicrobial stewardship

Antimicrobial stewardship: is an inter-professional effort, across the continuum of care

involves timely and optimal selection, dose and duration of an antimicrobial

for the best clinical outcome for the treatment or prevention of infection

with minimal toxicity to the patient

and minimal impact on resistance and other ecological adverse events

such as C. difficile”

13

Antimicrobial stewardship [AS] is one of the key strategies to

overcome resistance.

It involves the careful and responsible management of

antimicrobial use.

Nathwani et al., 2012

Page 14: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Goals of Antimicrobial stewardship

Page 15: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Goals of Antimicrobial stewardship

Improve infection cure rates

Reduce surgical infection rates

Reduce mortality and morbidity

15

Goal 1:

Improve patient outcomes

Page 16: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Goals of Antimicrobial stewardship

Reduce antimicrobial

consumption, without increasing

mortality or infection-related

readmissions e.g. 22%-36%

reduction in antimicrobial use

[Dellit et al., 2007].

Reduce C. difficile colonization or

infection by controlling the use of

“high-risk” antibiotics [Valiquette

et al,. 2007].

16

Goal 2:

Improve patient safety

Page 17: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Goals of Antimicrobial stewardship

Restricting relevant agents

can reduce colonization or

infection with Gram-

positive or Gram-negative

resistant bacteria.

17

Goal 3:

Reduce Resistance

Adapted from Lafaurie et al., J. Antimicrob. Chemother.

2012;67:1010-5.

Page 18: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Goals of Antimicrobial stewardship

Savings achieved by

reducing antibiotic costs

can be greater than the

cost of the intervention or

program (from $200,000 to

$900,000 depending on

the studies) [Dellit et al.,

2007]. Such cost-

effectiveness data are

sparse but emerging

[Stevenson et al., 2012;

Davey et al., (Cochrane

Database), 2013].

18

Goal 4:

Reduce Health care cost

Page 19: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Implementation of Antimicrobial

Stewardship Programs

Page 20: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Implementation of Antimicrobial

Stewardship Programs

20

Page 21: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Antimicrobial Stewardship Programs

21

www/cdc.gov/getsmart/healthcare/inpatient-stewardship

Page 22: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Antimicrobial Stewardship Programs

EIGHT KEY STEPS for implementing an Antimicrobial

Stewardship Program (ASP)

1.Assess the motivations

2.Ensure accountability and leadership

3.Set up structure and organization

4.Define priorities and how to measure progress and success

5.Identify effective interventions for your setting

6.Identify key measurements for improvement

7.Educate and Train

8.Communicate 22

Page 23: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Identify effective interventions

23

When establishing a new stewardship program, it is best to start

with the core strategies and focus on achieving and maintaining

them before adding some of the supplemental strategies

Page 24: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

ASP Strategies

Two core ASP strategies “Front–end strategies” where antimicrobials are made available through

an approval process (formulary restrictions and preauthorization).

“Back-end“ strategies” are where antimicrobials are reviewed after

antimicrobial therapy has been initiated (prospective audit with

intervention and feedback)

More labour intensive

Widely practiced

Easily accepted by clinians

Provide more sustained impact

−Chung et al 2013)

24

Page 25: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

25

ASP Strategies

Page 26: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

ASP Strategies Front–end strategies

26

Hospital ASPs should include an Antimicrobial Prescribing Policy

that is regularly reviewed and updated.

Antimicrobial Prescribing Policy

Page 27: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

ASP Strategies Back-end strategies

Antimicrobial review methods

Adapted from Johannsson B. et al. Inf. Control. Hosp. Epidemiol. 2011; 32:367-374.

Page 28: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

ASP Strategies Back-end strategies

Audit and direct feedback to prescribers The audit and feedback process

can be managed by either the

medical infection specialist or

specialist pharmacist

Appropriate use of guidance,

Indication for antibiotic,

Choice of agent,

Route [IV vs. oral] of

administration of treatment,

Timeliness of treatment,

Likelihood of on-going

infection or not,

Use of investigation,

Interpretation of microbiology

with a view to de-escalation or

stopping therapy,

Duration of therapy.

Adapted from Malcolm W, Nathwani D, et al. Antimicrob. Resist. infect. Control. 2012;2:3.

Page 29: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

ASP Strategies Back-end strategies

Use of diagnostic tools

The role of rapid diagnostics and biomarkers in antimicrobial

stewardship is recognized as a key recommendation by the IDSA.

Page 30: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

ASP Strategies Back-end strategies

Use of diagnostic tools

Fast, accurate identification and susceptibility testing, will achieve better

clinical outcomes and timely streamlining/de-escalating of empiric broad-

spectrum antibiotics in seriously ill patients.

End Point Reading

Informative Microbiology

culture results Provides Resistant Phenotypes

Eg. ESBL, MBL, ampC, MRSA, etc

MIC results along with PK/PD could help

in reviewing optimal dose

Page 31: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Prognostic value of Serum PCT

Typical course of PCT serum level according to patient’s response to antibiotic treatment (n=109)

F. Stüber, University Bonn, Lecture at ISICEM, Brussels 2001

ASP Strategies Back-end strategies

Use of diagnostic tools

Page 32: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

32

Meisner. M., 2010

ASP Strategies Back-end strategies

Use of diagnostic tools

Prognostic value of Serum PCT

Page 33: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Surveillance of antimicrobial use and

Resistance

Surveillance of antimicrobial use and resistance is important At hospital, local and national level

Adapt empiric treatment according to local resistance trends

Demonstrate changes in practice over time.

Identify wards with high antimicrobial usage or use of non-

policy antimicrobials and define targeted interventions

required

Measure improvement after implemented interventions 33

Page 34: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

34

Further reading…

Page 35: Antibiotic stewardship,medic1.upm.edu.my/jmpp/event/nidsaw/images/5.pdf · Présentation PowerPoint Author: Nathalie Created Date: 9/10/2013 10:39:54 AM

Thank you very much